Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .

The lab of The Wistar Institute’s Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Despite advances in treatments and improvements in survival overall, many oncologists remain hesitant to tell patients ...

Melanoma is deadlier for Black individuals due to late diagnoses and hidden symptoms. Understanding the risks can save lives.

"Who’s making their appointment today?" the TV personality, who has documented her melanoma journey on social media, asked in ...

This combination showed promising results in topically accessible tumors like melanoma and breast cancer models: The therapy led to the death of tumor cells at the treated sites and simultaneously ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

However, a series of tests said it was nothing to worry about. But the line got darker — and in three months, she was told ...

Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...